Name | Symbol | Markt | Aktientyp |
---|---|---|---|
TriSalus Life Sciences Inc | TLSIW | NASDAQ | Equity Warrant |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
1,62 | 1,62 | 1,62 | 1,63 | 1,63 |
Aktuelle News
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
14.6.2024 | 12:16 | EDGAR2 | Form S-1 - General form for registration of securities under.. |
24.5.2024 | 13:06 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
24.5.2024 | 13:05 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
24.5.2024 | 12:46 | EDGAR2 | Form SC TO-I - Tender offer statement by Issuer |
24.5.2024 | 12:10 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
24.5.2024 | 12:10 | EDGAR2 | Form 8-K - Current report |
24.5.2024 | 12:04 | EDGAR2 | Form S-4 - Registration of securities, business combinations |
21.5.2024 | 23:38 | EDGAR2 | Form 3/A - Initial statement of beneficial ownership of.. |
15.5.2024 | 15:07 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
15.5.2024 | 14:30 | EDGAR2 | Form 8-K - Current report |
07.5.2024 | 23:56 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
07.5.2024 | 23:54 | EDGAR2 | Form 3 - Initial statement of beneficial ownership of.. |
07.5.2024 | 22:08 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
07.5.2024 | 22:01 | EDGAR2 | Form 8-K - Current report |